New Zealand markets closed

Talis Biomedical Corporation (TLIS)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
9.30+0.02 (+0.22%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-62,007
-62,007
-113,012
-192,036
-91,130
Depreciation & amortisation
770
770
8,830
1,578
763
Stock-based compensation
4,351
4,351
5,368
9,207
3,683
Change in working capital
-3,424
-3,424
-7,686
8,824
-951
Accounts receivable
259
259
-125
288
-238
Accounts payable
-2,429
-2,429
-1,194
216
3,200
Other working capital
-53,726
-53,726
-101,751
-174,250
-95,225
Other non-cash items
4,304
4,304
2,771
1,043
611
Net cash provided by operating activities
-53,240
-53,240
-100,136
-171,384
-87,024
Cash flows from investing activities
Investments in property, plant and equipment
-486
-486
-1,615
-2,866
-8,201
Net cash used for investing activities
-486
-486
-1,615
-2,866
-8,201
Cash flows from financing activities
Common stock issued
-
-
0
232,546
0
Other financing activities
-
-
-
-
-1,451
Net cash used provided by (used for) financing activities
33
33
406
234,429
246,754
Net change in cash
-53,693
-53,693
-101,345
60,179
151,529
Cash at beginning of period
131,967
131,967
233,312
173,133
21,604
Cash at end of period
78,274
78,274
131,967
233,312
173,133
Free cash flow
Operating cash flow
-53,240
-53,240
-100,136
-171,384
-87,024
Capital expenditure
-486
-486
-1,615
-2,866
-8,201
Free cash flow
-53,726
-53,726
-101,751
-174,250
-95,225